• Home
  • Products
  • Formulations
  • Formulation Forum
  • Insights
  • Low 1,4-Dioxane
  • Sustainability
  • Contact
  • What it means to be on the EPA List N* and CBC list**

    The outbreak of the novel Coronavirus, SARS-CoV-2, the cause of COVID-19, has businesses and consumers alike seeking solutions to respond to the pandemic.

    In the midst of widespread misinformation about COVID-19, the EPA List N: Disinfectants for Use Against SARS-CoV-2, has emerged as a resource for selecting products to fight the outbreak. The products on EPA List N have been vetted by the EPA for fighting this virus because, first, there is a rigorous process involved for a product to even be registered by the EPA as a pesticide, and second, additional steps are then required to comply with the EPA’s Emerging Viral Pathogens Policy.

    Emerging viral pathogens have been defined as infectious diseases/pathogens “that have newly appeared in a population or have existed but are rapidly increasing in incidence or geographic range,” according to the National Institute of Allergy and Infectious Diseases. EPA’s Emerging Viral Pathogens Policy was designed to help address these pathogens, such as SARS-CoV-2.

    The EPA notes:

    “Because the occurrence of emerging viral pathogens is less common and predictable than established pathogens, few if any EPA-registered disinfectant product labels specify use against this category of infectious agents. Therefore, in 2016, EPA provided a voluntary, two-stage process to enable use of certain EPA-registered disinfectant products against emerging viral pathogens not identified on the product label.”

    The EPA Policy allows an emerging viral pathogens claim to be made “based on previous EPA-approved claims for harder-to-kill viruses.”

    * Environmental Protection Agency List N: Disinfectants for Use Against SARS-CoV-2

    ** Center for Biocide Chemistries Novel Coronavirus (COVID-19)-Fighting Products List

    Solutions for Novel Coronavirus

    BASF has a product included on the EPA “List N” as well as the CBC (Center for Biocide Chemistries) list of “Novel Coronavirus (COVID-19) – Fighting Products” for use during the COVID-19 pandemic.

    This product is Aseptrol® S10-Tab (EPA Reg. No. 70060-19). BASF's distributor Quip Laboratories, Inc. (Quip Labs) distributes this product commercially as MB-10 Tablets (EPA Reg. No. 70060-19-46269). MB-10 Tablets (EPA Reg. No. 70060-19-46269) has demonstrated effectiveness against a similar virus to SARS-CoV-2 on hard, non-porous surfaces. Therefore, MB-10 Tablets (EPA Reg. No. 70060-19-46269) can be used against SARS-CoV-2 when used in accordance with the directions for use against Norovirus (Feline Calicivirus) and Porcine Circovirus on hard, non-porous surfaces. Refer to the CDC website for additional information

    EPA Registration Number #70060-19

    Viricidal Efficacy

    We know that SARS-CoV-2 is not the only concern facing hospitals and other clinical settings exposed to a variety of pathogenic organisms, which is why it’s critical that disinfectants, such as MB-10 Tablets, are efficacious against a broad spectrum of bacteria and viruses. When used as directed on hard, non-porous surfaces, MB-10 Tablets have demonstrated efficacy against these viruses:

    • HIV-1
    • Norovirus
    • Ebola Virus
    • Hepatitis B Virus
    • Hepatitis C Virus
    • Swine Influenza A Virus
    • Avian Influenza A Virus
    • Influenza A Virus

    MB-10 Tablets have also demonstrated efficacy as a disinfecting agent on hard, non-porous surfaces against bacteria including Salmonella enterica, Helicobacter pylori (H. pylori), Escherichia coli (E. coli) O157:H7, and Staphylococcus aureus (ATCC 6538 and MRSA).

    Please see the label for additional viruses and other pathogens.

    Formulation matters

    MB-10 Tablets present a convenient method on the market for leveraging the benefits of chlorine dioxide in hygiene applications. The tablet form is fairly unique in this category, and makes MB-10 Tablets easy to use, easy to store, and easy to ship.

    Multiple use sites

    MB-10 Tablets have multiple use areas across a variety of settings, including:

    • Health care facilities (hospitals and other clinical settings)
    • Institutional and industrial facilities
    • Veterinary facilities
    • Laboratory and animal facilities
    • Facilities where food contact surfaces require sanitization

    Fighting forward, together

    Our primary goal is to aid in the efforts to stop the spread of SARS-CoV-2 and focus on the health and safety of our global community.

    We encourage anyone interested in learning more about how to fight this pandemic to refer to EPA List N and CBC list to become better informed on product options. For more information on MB-10 Tablets and how they can be used in your facility, visit the Quip Laboratories, Inc. website.

    Important information about the EPA List N and CBC list

    EPA List N and the CBC list are both important sources of information for disinfectants expected to be effective against SARS-CoV-2. The CBC list from the American Chemistry Council (ACC) includes products pre-approved by the EPA for use against emerging viral pathogens and/or have a Human Coronavirus claim. This list is not intended to be exhaustive and, while the CBC has made efforts to ensure the information on the list is accurate and products included are suitable for use during the COVID-19 outbreak, the CBC cannot make a formal determination of the effectiveness of a product in fighting pathogens like COVID-19.

    Products on the EPA List N are expected to be effective against SARS-CoV-2 because they have:

    • “Demonstrated efficacy against a harder-to-kill virus;
    • Qualified for the emerging viral pathogens claim; or
    • Demonstrated efficacy against another human coronavirus similar to SARS CoV-2.”

    While this is stringent criteria, as with the CBC list, products on the EPA List N have not yet been specifically tested against SARS-CoV-2. The EPA notes: “SARS-CoV-2 is a new virus. Such pathogens are often unavailable commercially for laboratory testing.”

    When purchasing a product with the intention of combatting the SARS-CoV-2 outbreak, check the product to see if its EPA registration number is on List N. “If it is, you have a match and the product can be used against SARS-CoV-2,” the EPA says on its website.